The Sotac Pharmaceuticals date has been confirmed from March 29 and ended on April 3. Read the post to learn about Sotac Pharmaceuticals IPO GMP.
The Sotac Group’s Sotac Pharmaceuticals manufactures pharmaceutical goods for guests on a loan license and contract manufacturing base. They presently have 162 commercial guests.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Sotac Pharmaceuticals IPO:
Bidding Dates
March 29 – April 3
Price Range
₹105 to ₹111 per share
Face Value
₹10 per share
GMP
₹10
Sotac Pharmaceuticals GMP
The Sotac Pharmaceuticals IPO GMP Today is ₹[10].
Sotac Pharmaceuticals IPO Overview
Sotac Pharmaceuticals IPO is a book erected issue of Rs33.30 crores. The issue is entirely a fresh issue of 30 lakh shares.
Sotac Pharmaceuticals IPO bidding started from March 29, 2023 and ended on April 3, 2023. The allotment for Sotac Pharmaceuticals IPO was perfected on Monday, April 10, 2023. The shares got listed on NSE SME on April 13, 2023.
Sotac Pharmaceuticals IPO price band is set at ₹ 105 to ₹ 111 per share. The minimal lot size for an operation is 1200 Shares. The minimal quantum of investment needed by retail investors is ₹ 133,200. The minimal lot size investment for HNI is 2 lots( 2,400 shares) amounting to ₹ 266,400.
Sotac Pharmaceuticals IPO Date & Price Band Details
| IPO Date | March 29, 2023 to April 3, 2023 |
| Listing Date | April 13, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹105 to ₹111 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 3,000,000 shares (aggregating up to ₹33.30 Cr) |
| Fresh Issue | 3,000,000 shares (aggregating up to ₹33.30 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 150,000 shares |
Sotac Pharmaceuticals IPO Market Lot
Investors can bid for a minimum of 1200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Applications | Lots | Shares | Amount |
| Retail (Min) | 1 | 1200 | ₹133,200 |
| Retail (Max) | 1 | 1200 | ₹133,200 |
| HNI (Min) | 2 | 2,400 | ₹266,400 |
Sotac Pharmaceuticals IPO Allotment & Listing Dates
Sotac Pharmaceuticals IPO opens on March 29, 2023, and closes on April 3, 2023.
| IPO Open Date | Wednesday, March 29, 2023 |
| IPO Close Date | Monday, April 3, 2023 |
| Basis of Allotment | Monday, April 10, 2023 |
| Initiation of Refunds | Tuesday, April 11, 2023 |
| Credit of Shares to Demat | Wednesday, April 12, 2023 |
| Listing Date | Thursday, April 13, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on April 3, 2023 |
Sotac Pharmaceuticals Company Financial Report
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
| 31-Mar-20 | 3,038.21 | 2,882.64 | 8.75 | 305.73 | 75.73 | 15.13 |
| 31-Mar-21 | 3,469.75 | 4,894.97 | -236.54 | 249.36 | 19.36 | 1,035.80 |
| 31-Mar-22 | 3,525.35 | 7,337.02 | 287.86 | 662.19 | 432.19 | 1,134.59 |
| 30-Sep-22 | 6,461.60 | 3,994.65 | 46.55 | 797.41 | 567.41 | 2,185.52 |
Sotac Pharmaceuticals Company Financials
| Particulars | 6 months ending in September 30,2022 | Year ending on March 31, 2022 (₹ lakh) | Year ending on March 31, 2021 |
| Revenue from Operations | 3,974.83 | 7,314.17 | 4,884.32 |
| Profit After Tax (PAT) (consolidated) | 46.55 | 287.86 | 236.54 |
| PAT Margin | 9.98% | 4.61% | 1,97% |
| EBITDA | 534.44 | 613.52 | 280.12 |
| EBITDA % | 17.32% | 8.36% | 6.44% |
| Period Ended | As on March 31, 2022 | As on March 31, 2021 | As on March 31, 2020 |
| Current Asset | 2,727.32 | 1,332.70 | 1,307.15 |
| Current Liability | 2,118.78 | 1,094.97 | 1,051.75 |
Company Profile
Sotac Group is a leading pharmaceutical manufacturer in India specializing in manufacturing a wide range of pharmaceutical products similar as tablets( general & beta- lactam), capsules( General & beta- lactam), oral liquid, dry saccharinity and external medications. The association is committed to furnishing numerous healthcare professionals with a wide range of quality and affordable pharmaceutical products. We’d endeavour to be one of the country’s leading manufacturing and development service providers in the transnational
As our thing is to come one of the leading manufacturers in India, we feed to a broad diapason of requirements that may pertain to expression development, clinical batch product, marketable scale products, and packaging.
Registrar Info
| Name | Kfin Technologies Limited |
| Phone number | 04067162222, 04079611000 |
| Email ID | [email protected] |
| Website | https://kosmic.kfintech.com/ipostatus/ |
Contact Details
| Name | Sotac Pharmaceuticals |
| Phone number | +91 90819 93300 |
| Email ID | [email protected] |
| Website | http://www.sotacpharma.com/ |
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Sotac Pharmaceuticals FAQs
When Sotac Pharmaceuticals IPO will open?
The Sotac Pharmaceuticals IPO opens on March 29, 2023 and closes on April 3, 2023.
What is the lot size of Sotac Pharmaceuticals IPO?
Sotac Pharmaceuticals IPO lot size is 1200 Shares, and the minimum amount required is ₹133,200.
When is Sotac Pharmaceuticals IPO allotment?
The finalization of Basis of Allotment for Sotac Pharmaceuticals IPO will be done on Monday, April 10, 2023, and the allotted shares will be credited to your demat account by Wednesday, April 12, 2023.
When is Sotac Pharmaceuticals IPO listing date?
The Sotac Pharmaceuticals IPO listing date is on April 13, 2023.
Leave a Reply